Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acquired immunodeficiency syndrome
adverse drug reaction
alkylating agents
amphiphysin antibodies
antihistamines
atypical
autoantibodies
autoimmune disease
autonomic dysfunction
autonomic neuropathy
azathioprine
B cell lymphocytes
Barkhof MR criteria for MS
bone marrow suppression
carcinoma
carcinoma of breast
carcinoma of lung
central nervous system, infection of
cerebellar atrophy, secondary
cerebellar degeneration
cerebral cortex
cerebral cortical atrophy
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, oligoclonal IgG in
cerebrovascular accident, secondary prevention
cladribine
clemastine fumarate
clinicoradiologic dissociation
collapsin response mediator protein 5 IgG
complications
contactin associated protein like 2 antibodies
controversies in neurology
cop 1
cost effectiveness
cyclophosphamide
cyclosporine
dermatomyositis
disability rating scale, neurological
disability, neurological
disease modifying agents
efficacy
encephalitis, autoimmune
encephalitis, brainstem
encephalitis, paraneoplastic
encephalitis, viral
encephalomyelitis
epidemiology of neurology
evoked potentials
flu-like illness
gadolinium
gait disorder
gammaglobulin therapy, intravenous
ganglionitis
gray matter
herpes virus infection
highly active antiretroviral therapy
human immunodeficiency virus type 1
hypertension
immune reconstitution inflammatory syndrome
immunocompetent
immunologic disease
immunology and the nervous system
immunomodulation
immunosuppression
immunosuppressive agents
immunotherapy
impotence
infection
interferon
interferon beta 1-a
interferon beta 1-b
JC virus
leucine rich glioma inactivated 1 antibodies
limbic encephalitis
malignancy screen
malignancy, occult
methotrexate
middle cerebellar peduncle
middle cerebellar peduncle, lesion
misdiagnosis
mitoxantrone
monoclonal antibodies
mononeuritis multiplex
motor neuron disease
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, contrast enhanced, delayed
MRI, contrast enhanced, high dose
MRI, demyelinating disease
MRI, diffusion tensor
MRI, diffusion weighted
MRI, false negative
MRI, serial
MRI, volumetry
MRS
multiple sclerosis
multiple sclerosis, benign form of
multiple sclerosis, chronic progressive
multiple sclerosis, clinical patterns
multiple sclerosis, cost of
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, misdiagnosis
multiple sclerosis, monosymptomatic
multiple sclerosis, prognosis
multiple sclerosis, prophylaxsis
multiple sclerosis, relapsing
multiple sclerosis, secondary progressive
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
myasthenia gravis, paraneoplastic
myasthenic syndrome
myelopathy
myelopathy, necrotizing
natalizumab
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neurologic disease, multifocal
neurologic examination
neurologic practice
neuromuscular junction
neuronal cell surface antigen
neuronopathy, sensory
neuropathology
neuropathy
neuropathy, paraneoplastic
neuropathy, peripheral
NMDA antagonists
ocrelizumab
onconeural antibodies
opsoclonus-myoclonus syndrome
paraneoplastic cerebellar degeneration
paraparesis
paraparesis, spastic
peripheral nerve, lesion of
placebo
plasmapheresis
pleocytosis of cerebrospinal fluid
practice guidelines
prognosis
progressive multifocal leucoencephalopathy
progressive neurologic disorder
psychological testing
quality of life
ReBUILD study
Red flags
rehabilitation for neurologic disorders
remote effect of cancer on the nervous system
remyelination
renal failure
retinopathy
review article
safety
screening
Sjogren's syndrome
Sjogren's syndrome, neurologic manifestations of
steroid
steroid therapy, CNS treatment and complications with
thrombocytopenia
treatment of neurologic disorder
tumor necrosis factor
viral infection
viral infection, CNS
viral infection, reactivation
visual evoked response
visual loss
wheelchair
white matter disease
white matter, dirty-appearing
workup
xerophthalmia
xerostomia
Showing articles 750 to 800 of 6235 << Previous Next >>

Tick-Borne Encephalitis
Lancet 371:1861-1871, Lindquist,L. &Vapalahti,O., 2008

Mlutiple Sclerosis Risk After Optic Neuritis: Final Optic Neuritis Treatment Trial Follow-Up
Arch Neurol 65:727-732, The Optic Neuritis Study Group, 2008

Hyperdense Internal Carotid Artery Sign: A CT Sign of Acute Ischemia
Stroke 39:2011-2016, Ozdemir,O.,et al, 2008

Genetics of Familial Amyotrophic Lateral Sclerosis
Neurol 70:144-152, Valdmanis,P.N. &Rouleau,G.A., 2008

Melanoma Complicating Treatment with Natalizumab for Multiple Sclerosis
NEJM 358:647-648, Mullen,J.T.,et al, 2008

Finding NMO: Neuromyelitis Optica in Chidlren
Neurol 70:334-335, Levy,M.,et al, 2008

Mitoxantrone as Induction Treatment in aggressive Relapsing Remitting Multiple Sclerosis: Treatment Response Factors in a 5 Year Follow-up Observational Study of 100 Consecutive Patients
JNNP 79:52-56, Le Page,E.,et al, 2008

Unexpected Multiple Sclerosis: Follow-Up of 30 Patients With Magnetic Resonance Imaging and Clinical Conversion Profile
JNNP 79:195-198,112, Lebrun,C.,et al, 2008

Primary Lateral Sclerosis With HIV-1 Infection
Neurol 70:575-577, Verma,A. &Berger,J.R., 2008

B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis
NEJM 358:676-688, Hauser,S.L.,et al, 2008

Diagnosis and Management of Motor Neurone Disease
BMJ 336:658-662, McDermott,C.J. &Shaw,P.J., 2008

Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008

Do Oligoclonal Bands Add Information to MRI in First Attacks of Multiple Sclerosis?
Neurol 70:1079-1083,1059, Tintore,M.,et al, 2008

Interferon �-Associated Retinopathy in Patients Treated for Multiple Sclerosis
Neurol 70:1153-1155, Folden,D.V.,et al, 2008

Complete Ophthalmoplegia: An Unusual Sign of Bilateral Paramedian Midbrain-Thalamic Infarction
Stroke 39:1355-1357, Thurtell,M.J. &Halmagyi,M., 2008

An Approach to the Diagnosis of Acute Transverse Myelitis
Semin Neurol 28:105-120, Jacob, A.,et al, 2008

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Bal�s Disease Showing Benign Clinical Course and Co-Existence with Multiple Sclerosis-Like Lesions in Chinese
Multiple Sclerosis 14:418-424, Wang,C.,et al, 2008

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Non-Communicating Syringomyelia: A Feature of Spinal Cord Involvement in Multiple Sclerosis
Brain 131:1776-1782, Weier,K.,et al, 2008

Non-Paraneoplastic Limbic Encephalitis Associated with Anti-Glutamic Acid Decarboxylase Antibodies
J Neuroimmunol 199:155-159, Mata,S.,et al, 2008

Spectrum of Neurological Syndromes Associated with Glutamic Acid Decarboxylase Antibodes: Diagnostic Clues for this Association
Brain 131:2553-2563, Saiz,A., et al, 2008

Brain Magnetic Resonance Imaging Abnormalities in Neuromyelitis Optica
Acta Neurol Scand 118:218-225, Li, Y.,et al, 2008

Risk Factors of Cerebral Vein and Sinus Thrombosis
Front Neurol Neurosci 23:23-54, de Freitas, G.R. & Bogousslavsky, J., 2008

Quantitative Assessment of Iron Accumulation in the Deep Gray Matter of Multiple Sclerosis by Magnetic Field Correlation Imaging
AJNR 28:1639-1644, Ge,Y.,et al, 2007

Neutralizing Antibodies to Interferon Beta: Assessment of Their Clinical and Radiographic Impact: An Evidence Report: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 69:1552-1553, Sorenson,P.S. &Bertolotto,A., 2007

Primary Central Nervous System Vasculitis: Analysis of 101 Patients
Ann Neurol 62:442-451,430, Salvarani,C.,et al, 2007

Efficacy of Folic Acid Supplementation in Stroke Prevention: A Meta-Analysis
Lancet 369:1876-1882,1841, Wang,X.,et al, 2007

Palliative Care for Patients With Amyotrophic Lateral Sclerosis
JAMA 298:207-216,248, Mitsumoto,H. &Rabkin,J.G., 2007

Natalizumab (Tysabri) Treatment for Relapsing Multiple Sclerosis
The Neurologist 13:182-187, Johnson,K.P., 2007

Effect of Early Verus Delayed Interferon Beta-1b Treatment on Disability After a First Clinical Event Suggestive of Multiple Sclerosis: A 3-Year Follow-Up Analysis of the BENEFIT Study
Lancet 370:389-397, Kappos,L.,et al, 2007

What Do We Really See When We Look at Magnetic Resonance Images?
Ann Neurol 62:207-208, Filippi,M. &Hartung,H.-P., 2007

Rehabilitation for Spatial Neglect Improves Test Performance But Not Disability
Stroke 38:2869-2870, Bowen,A. &Lincoln,N.B., 2007

Treatment of Physicians With Epilepsy
Neurol 69:1374-1379, Allen,J.W. &Devinsky,O., 2007

Parental Transmission of MS in a Population-Based Canadian Cohort
Neurol 69:1208-1212,1202, Herrera,B.M.,et al, 2007

Thalamic Atrophy and Cognition in Multiple Sclerosis
Neurol 69:1213-1223, Houtchens,M.K.,et al, 2007

Mangnetic Resonance Imaging Effects of Interferon Beta-1b in the BENEFIT Study: Integrated 2-Year Results
Arch Neurol 64:1292-1298, Barkhof,F.,et al, 2007

Cerebral Cortical and White Matter Lesions in Amyotrophic Lateral Sclerosis With Dementia; Correlation With MR and Pathologic Examinations
AJNR 28:1505-1510, Matsusue,E.,et al, 2007

Daclizumab Phase II Trial in Relapsing and Remitting Multiple Sclerosis
Neurol 69:785-789, Rose,J.W.,et al, 2007

Predictors of Fitness to Drive in People With Parkinson Disease
Neurol 69:1434-1441, Devos,H.,et al, 2007

The Incidence and Significance of Anti-Natalizumab Antibodies: Results from AFFIRM and SENTINEL
Neurol 69:1391-1403,1396, Calabresi,P.A.,et al, 2007

Lead Poisoning From the Beauty Case: Neurologic Manifestations in an Elderly Woman
Neurol 69:929-930, Fluri,F.,et al, 2007

Guidelines For Using Proton MR Spectroscopy in Multicenter Clinical MS Studies
Neurol 69:1942-1952, De Stefano,N.,et al, 2007

Long-Term Prognosis in Children With Neonatal Seizures: A Population-Based Study
Neurol 69:1816-1822, Ronen,G.M.,et al, 2007

Health-Related Quality of Life in Multiple Sclerosis: Effects of Natalizumab
Ann Neurol 62:335-346, Rudick,R.A.,et al, 2007

Effect of Urgent Treatment of Transient Ischaemic Attack and Minor Stroke on Early Recurrent Stroke (EXPRESS Study): A Prospective Population-Baed Sequential Comparison
Lancet 370:1432-1442,1398, Rothwell,P.M., et al, 2007

Diagnosis and Treatment of Neuromyelitis Optica
The Neurologist 13:2-11, Wingerchuk,D.M., 2007

Longitudinal Follow-Up of "Benign" Multiple Sclerosis at 20 Years
Neurol 68:496-500,480, Sayao,A-L.,et al, 2007

Multiple Sclerosis After Infectious Mononucleosis
Arch Neurol 64:72-75, Nielsen,T.R.,et al, 2007

Electromyographic Biofeedback for the Recovery of Motor Function After Stroke
Stroke 38:1999-2000, Woodford,H.J. &Price,C., 2007



Showing articles 750 to 800 of 6235 << Previous Next >>